RA should be managed early by a
rheumatologist, because joint damage can occur within months. The goal is
remission or low disease activity using a treat-to-target plan, with regular assessment of swollen joints, pain, function, ESR/CRP, and medication toxicity.
NICE RA guidance recommends rapid specialist referral for suspected persistent inflammatory arthritis.
NICE recommends conventional DMARD treatment with escalation toward remission or low activity; biologic or targeted therapy is generally combined with methotrexate if it is tolerated.
NICE treatment recommendations